Drug and clinical candidate information for pde3a (ChEMBL ID: CHEMBL241):

Molecule: INAMRINONE LACTATE
ChEMBL ID: CHEMBL2096642
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: CILOSTAZOL
ChEMBL ID: CHEMBL799
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1999

Molecule: MILRINONE LACTATE
ChEMBL ID: CHEMBL1200977
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1987

Molecule: DYPHYLLINE
ChEMBL ID: CHEMBL1752
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1951

Molecule: IBUDILAST
ChEMBL ID: CHEMBL19449
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1989
Drug and clinical candidate information for pde3a (ChEMBL ID: CHEMBL2094125):

Molecule: THEOPHYLLINE SODIUM GLYCINATE
ChEMBL ID: CHEMBL1200578
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1982

Molecule: ANAGRELIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200759
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1997

Molecule: AMINOPHYLLINE
ChEMBL ID: CHEMBL1370561
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1940

Molecule: THEOPHYLLINE
ChEMBL ID: CHEMBL190
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1940

Molecule: OXTRIPHYLLINE
ChEMBL ID: CHEMBL1200434
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1981

Molecule: LEVOSIMENDAN
ChEMBL ID: CHEMBL2051955
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: K-134
ChEMBL ID: CHEMBL284838
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: ENOXIMONE
ChEMBL ID: CHEMBL249856
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ENSIFENTRINE
ChEMBL ID: CHEMBL4594287
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Small molecule
Drug and clinical candidate information for pde3a (ChEMBL ID: CHEMBL2363066):

Molecule: PENTOXIFYLLINE
ChEMBL ID: CHEMBL628
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1984

Molecule: DIPYRIDAMOLE
ChEMBL ID: CHEMBL932
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1961
